Women’s hearts: Biomarkers for precision-based care and biological discovery

Description

Women’s cardiovascular health is shaped by unique biological factors that are often underrecognized in clinical practice. This session explores sex-specific differences in cardiac biomarkers—including troponin and natriuretic peptides—highlighting their clinical relevance and diagnostic implications in female patients.

Participants will gain practical insights into how biomarker data can guide diagnosis and inform care strategies throughout a woman’s lifespan. The session also emphasizes the laboratory’s critical role in enabling personalized and preventive cardiovascular care.

Join us to discover how biomarker-driven strategies can support holistic, future-focused care for women.

Target audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, and other laboratory professionals overseeing/conducting within this topic.

Learning objectives

At the end of this session, participants will be able to:

• Recognize sex-based differences in cardiac biomarkers and their clinical relevance in women
• Identify female-specific risk factors for cardiovascular disease across different life stages
• Apply biomarker data to guide clinical decision-making and enhance preventive cardiovascular care for women

Faculty

Emily S. Lau, MD, MPH
Director, Women's Heart Health Program
Brigham and Women's Hospital Mass General Brigham Heart & Vascular Institute
Assistant Professor of Medicine, Harvard Medical School
Boston, MA

Disclosures and statement of independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

• Emily S. Lau, MD, MPH 
  • Consulting Fees: SystoleHealth, Inc.
  • Grant and/or Research Support: NIH/NHLBI, American Heart Association, Massachusetts Life Sciences Center, Dongqiao and Chrissy Chen Institute
  • Commitee/Advisory Board: Amissa Health and Roon

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation statement

This activity will be submitted for 1.0 ACCENT® continuing education credit.

Successful completion statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].